Gene Logic Inc. uses StaccatoTM to generate gene expression data
2001
Gene Logic Inc. Uses Staccato for Gene Expression Data
publication
Author Information
Author(s): Jordana Estner
Primary Institution: Zymark Corporation
Conclusion
Gene Logic Inc. will use Staccato technology to enhance their gene expression data generation and drug screening efforts.
Supporting Evidence
- Staccato's technology provides a uniform architecture for gene screening.
- Gene Logic aims to generate high-quality gene expression data.
- Zymark's goal is to help scientists get new drugs to market efficiently.
Takeaway
Gene Logic is using a new machine called Staccato to help them study many genes at once, which will make it easier to find new medicines.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website